MYNSIPO
Live / Registered — Registered (as of 08 Mar 2022)
What this means for you
Registered since 08 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79260489
- Registration number
- 6661706
- Mark type
- Stylized text
- Filed
- 08 Apr 2019
- Published for opposition
- 21 Dec 2021
- Registered
- 08 Mar 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 08 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 21 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Dec 2021 — PUBLISHED FOR OPPOSITION
- 01 Dec 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 01 Dec 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 01 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Oct 2021 — REG. CANCELLED - RESTORED TO PENDENCY
- 01 Jul 2021 — ASSIGNED TO PETITION STAFF
- 14 Jun 2021 — REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
- 04 Feb 2021 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 29 Jan 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 27 Jul 2020 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 29 May 2020 — REINSTATED
- 29 May 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Feb 2020 — CORRECTION TRANSACTION RECEIVED FROM IB